A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Dexmethylphenidate (Focalin)

Dexmethylphenidate treats ADHD and narcolepsy by increasing dopamine and norepinephrine activity.

First FDA approval2001-11-30
Generic availableYes · 13 mfrs
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$9.7M in CY2024 Part D spend122K claims · 28K beneficiaries · 329 plans surveyed

Lowest NADAC
$0.217/unit
20 NDCs benchmarked, lowest of all strengths.
Average NADAC
$0.473
Across all dosage forms in distribution.
Highest NADAC
$0.919
Range is tight.
Plans with PA
311 / 329
Limited PA friction.

Questions a plan sponsor actually asks.

FAQPage schema12 entries indexed · 4 visible
What is Dexmethylphenidate used for?

Dexmethylphenidate treats ADHD and narcolepsy by increasing dopamine and norepinephrine activity.

Is there a generic for Dexmethylphenidate?

Yes. 70 ANDAs filed at FDA, 13 generic manufacturers currently shipping.

How much does my plan pay for Dexmethylphenidate?

Across 329 Part D plans, Dexmethylphenidate averages $0.473/unit (NADAC). Lowest available: $0.217/unit. Highest in distribution: $0.919/unit.

Is Dexmethylphenidate on the FDA shortage list?

No. Dexmethylphenidate is not currently on the FDA Drug Shortage Database.

8 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Central Nervous System Stimulant6 alternatives in D1
01
Acetaminophen, Caffeine, Dihydrocodeine Bitartrate
Brand: Trezix
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
02
Amphetamine
Brand: Adzenys XR-ODT
$0.350Lowest NADAC
12Generic mfrs
$3.0MCY24 Part D spend
Compare →
03
Amphetamine Extended-Release
Central Nervous System Stimulant
$16.31Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
04
Caffeine
Brand: CAFCIT
Lowest NADAC
6Generic mfrs
CY24 Part D spend
Compare →
05
Caffeine and Sodium
Central Nervous System Stimulant
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
06
Dextroamphetamine
Brand: DEXEDRINE
$0.442Lowest NADAC
11Generic mfrs
$15.3MCY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.